FGFR2 FUSIONS

Clinical trials for FGFR2 FUSIONS explained in plain language.

Never miss a new study

Get alerted when new FGFR2 FUSIONS trials appear

Sign up with your email to follow new studies for FGFR2 FUSIONS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New targeted drug trial offers hope for Tough-to-Treat bile duct cancer

Disease control Recruiting now

This study is testing two different daily doses of an oral medication called futibatinib for people with advanced bile duct cancer that has a specific genetic change. The trial includes 120 patients whose cancer has worsened after previous chemotherapy treatment. Researchers want…

Matched conditions: FGFR2 FUSIONS

Phase: PHASE2 • Sponsor: Taiho Oncology, Inc. • Aim: Disease control

Last updated Apr 02, 2026 02:11 UTC

FGFR2 FUSIONS

Get alerted when new FGFR2 FUSIONS trials appear

New targeted drug trial offers hope for Tough-to-Treat bile duct cancer